Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Ayres

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Antimicrobial Agents and Chemotherapy|April 18, 2007
The L80I substitution in the reverse transcriptase domain of the hepatitis B virus polymerase is associated with lamivudine resistance and enhanced viral replication in vitroNadia Warner, Stephen Locarnini, Michael Kuiper, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 3, 2003
Lamivudine and Famciclovir resistant hepatitis B virus associated with fatal hepatic failureAnna Ayres, Angeline Bartholomeusz, George Lau, et al.
AIDS (London, England)|July 11, 2003
Prevalence and characterization of lamivudine-resistant hepatitis B virus mutations in HIV-HBV co-infected individualsLouise Cooley, Anna Ayres, Angeline Bartholomeusz, et al.
Journal of Virology|February 15, 2005
Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapyJ Judy Chang, Fiona Wightman, Angeline Bartholomeusz, et al.
Journal of Clinical Microbiology|August 7, 2004
Comparison of sequence analysis and a novel discriminatory real-time PCR assay for detection and quantification of Lamivudine-resistant hepatitis B virus strainsFiona Wightman, Tomos Walters, Anna Ayres, et al.
Antiviral Research|January 12, 2007
SeqHepB: a sequence analysis program and relational database system for chronic hepatitis BLilly K W Yuen, Anna Ayres, Margaret Littlejohn, et al.
Gastroenterology|August 2, 2003
Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerasePeter Angus, Rhys Vaughan, Shelly Xiong, et al.
Journal of Medical Virology|June 1, 2010
Molecular and clinical characteristics of hepatitis B virus in KoreaSang Hoon Ahn, Lilly Yuen, Kwang-Hyub Han, et al.
AIDS (London, England)|March 22, 2006
Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapyGail V Matthews, Angeline Bartholomeusz, Stephen Locarnini, et al.
The Medical Journal of Australia|May 6, 2009
Perinatal transmission of hepatitis B virus: an Australian experienceElke Wiseman, Melissa A Fraser, Sally Holden, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Antimicrobial Agents and Chemotherapy|April 18, 2007
The L80I substitution in the reverse transcriptase domain of the hepatitis B virus polymerase is associated with lamivudine resistance and enhanced viral replication in vitroNadia Warner, Stephen Locarnini, Michael Kuiper, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 3, 2003
Lamivudine and Famciclovir resistant hepatitis B virus associated with fatal hepatic failureAnna Ayres, Angeline Bartholomeusz, George Lau, et al.
AIDS (London, England)|July 11, 2003
Prevalence and characterization of lamivudine-resistant hepatitis B virus mutations in HIV-HBV co-infected individualsLouise Cooley, Anna Ayres, Angeline Bartholomeusz, et al.
Journal of Virology|February 15, 2005
Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapyJ Judy Chang, Fiona Wightman, Angeline Bartholomeusz, et al.
Journal of Clinical Microbiology|August 7, 2004
Comparison of sequence analysis and a novel discriminatory real-time PCR assay for detection and quantification of Lamivudine-resistant hepatitis B virus strainsFiona Wightman, Tomos Walters, Anna Ayres, et al.
Antiviral Research|January 12, 2007
SeqHepB: a sequence analysis program and relational database system for chronic hepatitis BLilly K W Yuen, Anna Ayres, Margaret Littlejohn, et al.
Gastroenterology|August 2, 2003
Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerasePeter Angus, Rhys Vaughan, Shelly Xiong, et al.
Journal of Medical Virology|June 1, 2010
Molecular and clinical characteristics of hepatitis B virus in KoreaSang Hoon Ahn, Lilly Yuen, Kwang-Hyub Han, et al.
AIDS (London, England)|March 22, 2006
Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapyGail V Matthews, Angeline Bartholomeusz, Stephen Locarnini, et al.
The Medical Journal of Australia|May 6, 2009
Perinatal transmission of hepatitis B virus: an Australian experienceElke Wiseman, Melissa A Fraser, Sally Holden, et al.
Pageof 2